Elanco Animal Health (ELAN) Operating Margin Growth (1y) (2018 - 2026)

Elanco Animal Health (ELAN) Operating Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 304.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -650.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 111.00
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 31.00

Historic Data

Download Data
DateValue
Mar 31, 2026 111.00
Dec 31, 2025 5,027.00
Sep 30, 2025 598.00
Jun 30, 2025 6,224.00
Mar 31, 2025 6,186.00
Dec 31, 2024 801.00
Sep 30, 2024 15,482.00
Jun 30, 2024 402.00
Mar 31, 2024 -1,103.00
Dec 31, 2023 -761.00
Sep 30, 2023 -9,802.00
Jun 30, 2023 -615.00
Mar 31, 2023 469.00
Dec 31, 2022 259.00
Sep 30, 2022 559.00
Jun 30, 2022 1,928.00
Mar 31, 2022 1,649.00
Dec 31, 2021 2,331.00
Sep 30, 2021 1,727.00
Jun 30, 2021 199.00